XML 50 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Revenue Recognition (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Revenue Recognition [Abstract] |
Schedule of Disaggregated Revenue |
Segment Net Sales |  |  |  |  |
MedSurg and Neurotechnology: | 2021 |  | 2020 |  | 2019
Instruments | $ | 2,111 |  |  | $ | 1,863 |  |  | $ | 1,959 |
Endoscopy | 2,141 |  |  | 1,763 |  |  | 1,983 |
Medical | 2,607 |  |  | 2,524 |  |  | 2,264 |
Neurovascular | 1,188 |  |  | 973 |  |  | 924 |
Neuro Cranial | 1,214 |  |  | 972 |  |  | 1,059 |
Other | 277 |  |  | 250 |  |  | 286 |
| $ | 9,538 |  |  | $ | 8,345 |  |  | $ | 8,475 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 1,848 |  |  | $ | 1,567 |  |  | $ | 1,815 |
Hips | 1,342 |  |  | 1,206 |  |  | 1,383 |
Trauma and Extremities | 2,664 |  |  | 1,722 |  |  | 1,639 |
Spine | 1,167 |  |  | 1,047 |  |  | 1,157 |
Other | 549 |  |  | 464 |  |  | 415 |
| $ | 7,570 |  |  | $ | 6,006 |  |  | $ | 6,409 |
Total | $ | 17,108 |  |  | $ | 14,351 |  |  | $ | 14,884 |
United States Net Sales |  |  |  |  |
MedSurg and Neurotechnology: | 2021 |  | 2020 |  | 2019
Instruments | $ | 1,637 |  |  | $ | 1,471 |  |  | $ | 1,542 |
Endoscopy | 1,670 |  |  | 1,408 |  |  | 1,577 |
Medical | 2,007 |  |  | 1,910 |  |  | 1,787 |
Neurovascular | 451 |  |  | 381 |  |  | 391 |
Neuro Cranial | 988 |  |  | 801 |  |  | 890 |
Other | 273 |  |  | 247 |  |  | 283 |
| $ | 7,026 |  |  | $ | 6,218 |  |  | $ | 6,470 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 1,351 |  |  | $ | 1,170 |  |  | $ | 1,347 |
Hips | 822 |  |  | 777 |  |  | 882 |
Trauma and Extremities | 1,866 |  |  | 1,139 |  |  | 1,051 |
Spine | 831 |  |  | 764 |  |  | 873 |
Other | 425 |  |  | 387 |  |  | 334 |
| $ | 5,295 |  |  | $ | 4,237 |  |  | $ | 4,487 |
Total | $ | 12,321 |  |  | $ | 10,455 |  |  | $ | 10,957 |
International Net Sales |  |  |  |  |
MedSurg and Neurotechnology: | 2021 |  | 2020 |  | 2019
Instruments | $ | 474 |  |  | $ | 392 |  |  | $ | 417 |
Endoscopy | 471 |  |  | 355 |  |  | 406 |
Medical | 600 |  |  | 614 |  |  | 477 |
Neurovascular | 737 |  |  | 592 |  |  | 533 |
Neuro Cranial | 226 |  |  | 171 |  |  | 169 |
Other | 4 |  |  | 3 |  |  | 3 |
| $ | 2,512 |  |  | $ | 2,127 |  |  | $ | 2,005 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 497 |  |  | $ | 397 |  |  | $ | 468 |
Hips | 520 |  |  | 429 |  |  | 501 |
Trauma and Extremities | 798 |  |  | 583 |  |  | 588 |
Spine | 336 |  |  | 283 |  |  | 284 |
Other | 124 |  |  | 77 |  |  | 81 |
| $ | 2,275 |  |  | $ | 1,769 |  |  | $ | 1,922 |
Total | $ | 4,787 |  |  | $ | 3,896 |  |  | $ | 3,927 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration